[Contribution of pyridinol-carbamate in ophthalmologic therapeutics].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy; D002219:Carbamates / Q000627:therapeutic use*; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000627:therapeutic use*; D012162:Retinal Degeneration / Q000188:drug therapy; D012164:Retinal Diseases / Q000188:drug therapy*; D012171:Retinal Vessels; D012173:Retinitis / Q000188:drug therapy; D013927:Thrombosis / Q000188:drug therapy
D002219:Carbamates; D011725:Pyridines
Apport du pyridinol-carbamate en thérapeutique ophtalmologique.